pharma QA – Page 106

Endotoxin Oos during hold-time study: facility, people, process root cause mapping

Root Cause Analysis of Endotoxin OOS in Hold-Time Studies: A Practical Guide In the pharmaceutical manufacturing environment, Out of Specification (OOS) results can have significant implications, especially regarding endotoxin levels…

Bioburden Spike Pre-Filtration during terminal sterilization: facility, people, process root cause mapping

Identifying and Addressing Bioburden Spikes Pre-Filtration during Terminal Sterilization in Pharmaceutical Manufacturing In the pharmaceutical manufacturing industry, the integrity of terminal sterilization processes is crucial, especially regarding parenteral dosage forms.…

Emulsion Inversion during inspection preparation: how to document deviations for FDA/EMA

Managing Emulsion Inversion during Inspection Preparation: A Compliance Investigation Guide In the realm of pharmaceutical manufacturing, ensuring the integrity of your formulations is critical, especially in the context of emulsion…

Unplanned Line Stoppage during hold-time study: risk assessment for patient safety and recall

Risk Assessment for Patient Safety Following Unplanned Line Stoppage during a Hold-Time Study In pharmaceutical manufacturing, an unplanned line stoppage during a hold-time study can pose significant risks to product…

Aseptic Gowning Deviation after maintenance intervention: risk assessment for patient safety and recall

Aseptic Gowning Deviation Investigation Post-Maintenance Intervention: Ensuring Compliance and Patient Safety Aseptic processing is pivotal in pharmaceutical manufacturing, particularly for parenteral dosage forms. When deviations occur—such as an aseptic gowning…

Odor Change during method transfer: mixing and sampling controls for QA review

Investigating Odor Changes during Method Transfers: Effective Controls for Quality Assurance Review Odor changes during method transfers can signal underlying issues that compromise product quality and regulatory compliance. This article…

Em Excursion In Grade A during PAI readiness: facility, people, process root cause mapping

Identifying the Root Causes of Em Excursions in Grade A During PAI Readiness In the pharmaceutical manufacturing industry, maintaining compliance with strict standards is crucial, particularly in sterile manufacturing areas…

Bioburden Spike Pre-Filtration during routine EM trending: facility, people, process root cause mapping

Mapping the Root Causes of Bioburden Spikes in Pre-Filtration During Routine Environmental Monitoring Trending Bioburden spikes in pre-filtration during routine environmental monitoring (EM) present significant challenges for pharmaceutical manufacturers, particularly…

Texture Variability after excipient change: GMP investigation and CAPA strategy

GMP Investigation and CAPA Strategy for Texture Variability Following Excipient Changes In the dynamic environment of pharmaceutical manufacturing, excipients play a crucial role in determining the quality of dosage forms.…

Filter Integrity Failure during routine EM trending: how to classify deviation and set disposition

Addressing Filter Integrity Failures during Routine Environmental Monitoring: A Comprehensive Investigation Guide In the highly regulated environment of pharmaceutical manufacturing, the failure of filter integrity during routine environmental monitoring (EM)…

Particulate Matter Oos during routine EM trending: FDA/MHRA investigation narrative and batch impact

Understanding OOS Results for Particulate Matter in Environmental Monitoring Trends: A Structured Investigation Particulate matter (PM) unexpectedly flagged as out-of-specification (OOS) during routine environmental monitoring (EM) can cause significant concerns…

Air Entrapment in cream manufacturing: packaging compatibility and stability justification

Investigating Air Entrapment in Cream Manufacturing: Ensuring Packaging Compatibility and Stability In pharmaceutical cream manufacturing, air entrapment can lead to significant quality issues, impacting both packaging compatibility and product stability.…